chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Flu like symptoms; Cramping; Hair is falling out; Chills; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), MUSCLE SPASMS (Cramping), ALOPECIA (Hair is falling out) and CHILLS (Chills) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), MUSCLE SPASMS (Cramping), ALOPECIA (Hair is falling out) and CHILLS (Chills). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), MUSCLE SPASMS (Cramping), ALOPECIA (Hair is falling out) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Child returned for PPD reading nurse 8/7/06 noticed left arm swollen, hot to touch. Notified Dr. Nurse assistant who gave shots failed to chart sites at time given, Charted sites on 8/7/06
Fever ranging from 100.4 to 101.2 and lasting from approximately 4 pm on 04/08 until about Noon on 04/09. An accelerated heart rate with occasional minor chest pain was also experienced during this time.
About 15 minutes after vaccine, I had red blotches on my neck and chest. Symptoms disappeared after 10 minutes. No treatment necessary.
Info has been received from a nurse concerning a 24 month old female who was vaccinated at 12 months of age with a dose of varicella virus vaccine live. On 9/6/05, the pt experienced a severe case of chickenpox. Subsequently, the pt recovered. It was noted that the father had developed shingles that required an ER visit prior to the child's outbreak. Unspecified medical attention was sought. No product quality complaint was involved. The pt's brother also developed chicken pox after vaccination with varicella virus vaccine live. Additional info has been requested.
When vaccine was being administered to the patient there was a malfunction in the retractable syringe.   The vaccine liquid was ejected out of the plunger side of the syringe almost like it exploded after the needle was put into the patient's arm.  Because of the malfunction, it is estimated that less than half of the vaccine dose got into the patient's arm.  Immediately  after this happened the patients arm  began to swell at the injection site.  It looked like a hard ball under the skin and the patient felt pain at the injection site. Patient stated that she would drive herself to the urgent care clinic as she believed the needle may have broken off in her arm.
While patient was shopping after receiving her vaccine she started feeling "pressure"/"tightening" in the left chest/shoulder area and then in the front and back of upper torso. She stated it continued to increase and became painful. Her respirations increased and she felt like she was panting. She states it didn't feel like her previous anaphylaxis where her throat "felt like a rubber chicken" and she was unable to speak and had swelling in her throat.
got his shot and ended up getting them anyway/Suspected vaccination failure; got his shot and ended up getting them anyway; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient's child. The age at vaccination was not reported. The patient had his Shingle shot and ended up getting shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation were unknown at the time of reporting. The follow up would not be possible as no contact details were available.
Inj; pneumococcal given at 930AM.  At 1330PM started with extreme fatigue.  Slept until 5pm awoke with not feeling well, body aches, "bones hurt" joint pain, H/A.  Contacted hospital 6/20/08 10AM; recommended clinic appt to eval. 3pm.
Things started with a very sore throat, headache, and fatigue. On 2/14 I tested positive at the doctor office on a PCR COVID-19 test. The doctor prescribed PAXLOVID and advised to treat symptomatically. Symptoms lasted a couple of days with fatigue lingered a couple of more days.
This spontaneous report was received from a nurse practitioner via a company representative refers to a female patient who under 18 months old. On an unknown date the patient was vaccinated with PROQUAD (Merck) (1 dose, route was also reported as injection, lot# and expiration date were unknown) (also reported as vaccine). Concomitant therapies included ibuprofen. On an unknown date the patient had hives on face, arms, and back after receiving PROQUAD (Merck). Patient was seen in the emergency room. The patient had sought for medical attention. The outcome of the event was unknown. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to a 15 year old patient (unspecified gender). On 23-JUN-2015, the patient was vaccinated with an improperly stored dose of GARDASIL (dose and route were not provided) (lot # K008931 exp. 04-MAR-2017; lot # K009482 exp. 06-MAR-2017) which was exposed to below 36F for 361.81 hours. The nurse was requesting assistance in determining revaccination. In addition, excursion below 32F (31.2F) started on 13-JUL-2015. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Headache; Muscle soreness/ muscle soreness and knots; Muscle soreness/ muscle soreness and knots; Severe joint pain; Muscle tightness; Chest pain; Moderate chills; Exhaustion; This is a spontaneous report from a contactable other healthcare professional (HCP) (patient). A 25-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EL3248) via an unspecified route of administration on right arm on 11Jan2021 06:30 at single dose for COVID-19 immunisation. Medical history included nail patella syndrome. Concomitant medication included ethinylestradiol, levonorgestrel (LESSINA), escitalopram. There was no other vaccine in four weeks. The patient had not COVID prior vaccination. The patient had not COVID tested post vaccination. The patient previously took amoxicillin and experienced allergies. The patient received the first dose of BNT162B2 (Brand: Pfizer, Lot number: EH9899) on right arm on 21Dec2020 16:00 PM for COVID-19 immunisation. First dose came with moderate muscle fatigue and joint pain, chills, headache and fatigue.  Events occurred 7 days post vaccination. Second dose had almost immediate side effects beginning post vaccination beginning with headache, then muscle soreness. Followed by severe joint pain and muscle tightness, including chest pain. Moderate chills. Exhaustion. Both instances were elevated with ibuprofen, water, and a night's rest. Upon waking after second dose side effects, muscle soreness and knots probably from muscle tightness night before. A muscle relaxant might have helped. All events started from 11Jan2021 17:00. No treatment received for muscle tightness and muscle disorder, treatment was received for the other remain events. The outcome of the event was recovering.
Fatigue started day after injection and has continued through current date.  Same for nausea and brain fog.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 08-MAR-2017, the patient was vaccinated with a improperly stored dose of VARIVAX lot # M023382 with an expiration date 11-MAY-2018 for prophylaxis (dose, route of administration and anatomical location were not reported). There was no adverse effect reported. Administered dose of VARIVAX experienced the temperature excursion of 7 degrees Fahrenheit, reported also as  from 6 degrees Fahrenheit to 14 degrees Fahrenheit (from -14 degrees Celsius to -10 degrees Celsius) for 30 minutes. A digital data logger was involved. There was no previous temperature excursion. This is one of several reports received from this reporter. Additional information has been requested.; Sender's Comments:  US-009507513-1703USA007869: , US-009507513-1703USA012358:
Information has been received from a health care professional concerning a female who on approximately 27AUG96 was vaccinated with MMR vaccine. On 17SEP96 the patient was diagnosed with juvenile rheumatoid arthritis. No further details were provided.
Information has been received from a physician concerning a 13 year old female who on 02-AUG-2007 was vaccinated with a first dose of Gardasil.  On 02-AUG-2007 the patient fainted.  Subsequently, the patient recovered from fainted.  It was reported that the patient did not seek medical attention.  Additional information has been requested.
Fever / Chills / Headache / Nausea all started on the same day as vaccine around 7pm. Resolved after 36hours. On 1/29 noticed rash from mid neck to shoulder to upper torso, breast, ears. Red and splotchy but not itchy. Rash resolved by 1/30 after a dose of Benadryl.
This is a prospective pregnancy case. This 40-year-old female subject was enrolled in a study. The subject received BOOSTRIX (intramuscular) .5 ml on 22nd October 2014. The subject's last menstrual period was on 24th March 2014 and estimated date of delivery was 29th December 2014. The subject received BOOSTRIX at week 30 of the pregnancy. On an unknown date, an unknown time after receiving BOOSTRIX the subject developed vaccine exposure during pregnancy (Non-serious). The outcome of vaccine exposure during pregnancy was unknown. The pregnancy was ongoing.
6/29/2021   Patient was observed post Covid-19 immunization for 15 minutes .  During the observation period, she experienced an adverse reaction with the following symptoms:  dizziness.   Assessment : Time of assessment 142pm. Alert and oriented and dizziness.   Actions taken:  Vitals sign taken  VAERS form obtained and completed by RN.  142pm- BP 148/100 _79, O2 99%, water given, kept in observation x 30 minutes. Recheck VS- BP- 140/88, P- 76, O2- 98 %, reports feeling better, recheck VS sitting- BP- 134/87, P- 72, O2- 99% , standing BP- 132/88, P- 84, O2- 99%       Medications administered: No medication administered.   Disposition: Reports no further symptoms of adverse reaction after observation for 30 minutes. Discharged home. Husband with patient.     Immunizations Administered    Name Date Dose Date Route   Pfizer COVID-19 Vaccine 6/29/2021  1:17 PM 0.3 mL 2/25/2020 Intramuscular   Manufacturer: Pfizer, Inc   Lot: ER8736
Knot in muscle; Arm Soreness; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th October 2019, the patient received the 1st dose of Shingrix (intramuscular). On 24th October 2019, less than a day after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the patient experienced nodule. On an unknown date, the outcome of the pain in arm was not recovered/not resolved and the outcome of the nodule was unknown.   It was unknown if the reporter considered the pain in arm and nodule to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix on left arm. The patient reported arm soreness with the first dose of Shingrix, that did not resolved.  The patient also reported having a "knot in muscle" that she had to stretch out. Patient was unable to provide lot number and expiration date. The reporter did not consent to follow-up. This case was linked to case US2020AMR089212 for same patient. This case was linked to case US2020088762 by same reporter.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 05-SEP-2013 the patient received an expired dose of ZOSTAVAX, 0.65 ml, subcutaneous. Lot number 0068AEM is not a valid lot number for ZOSTAVAX. No adverse effect was reported. Additional information has been requested.
I have had vision auras associated with headache/migraine in the past, but have not had one in over six years.  Three days after my second COVID vaccine shot, I had an aura.  The next day, I had another, and the following day, I had two.  Over the following week, I continued to have auras whenever I was in a room with bright light/sunlight.  The auras subsided after that week, and have not returned.
Night p/vax recvd pt devel fever of 104, had alot of "gagging" & severe diarrhea; mom states pt had t104 x 3 days & t102 x 2 days; Pt taken to MD 1 wk p/vax, MD felt pt had tonsillitis & OM; pt also sleepy & weak;
The patient received a vaccine in the Right deltoid at the High School clinic on Saturday, October 17. She stated that approximately 7 hours after she received her flu vaccine she developed swelling in her eye and face, discharge similar to pink eye, and a sore dry throat with slight difficulty breathing. When further asked she mentioned that she had body aches and chills. She denied having fever, nausea, vomiting, hives and denied having significant trouble breathing where she felt as though she needed medical attention. She and her husband did some research on the Internet and felt like she was developing ocular respiratory syndrome. She went to bed and slept through the night and woke with the only stickiness in the eyes remaining. She did not call her doctor, seek medical attention or call the helpline on Saturday or Sunday. I spoke with the patient on Tuesday, October 20 after she called the helpline to inquire if this was a "normal reaction" and if she could get a COVID vaccine when it was developed. On Tuesday, the patient denied all symptoms with the exception of slight pinkness in her eyes. She denied drainage. On Wednesday, October 21, the patient stated that all symptoms were gone, she felt back to normal and had made an appointment with her doctor next week to discuss future vaccinations. The patient stated that she has received the vaccine previously with no unusual reaction though it had been several years since she was last vaccinated.
pt recvd 1st dose of Hep B on 9FEB93 & 4 hrs following vax devel apneic episode, limpness & paleness; pt was admitted to a hosp; addtl details are being requested;
felt so bad; severe chest pain; Chest pain and arm pain; A spontaneous report was received from a consumer concerning her husband, a 71-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced abnormal feeling, severe chest pain,  and arm pain.   The patient's medical history, as provided by the reporter, included the patient had a heart attack on 26 May 2020 and on October 2020 the patient had five bypass, two arteries they took. Since October the patient's condition was stated to be great. Concomitant medications reported included Insulin Bovine, Multivitamins [vitamins Nos], acetylsalicylic acid and Medication related to patient's heart attack.  On 12 Feb 2021, unspecified days prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number:007M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 12 Feb 2021, post receiving mRNA-1273, the patient had no reaction and did not feel bad.  On unspecified day in Feb 2021 one week prior to the reporting the events, the patient experienced chest pain and arm pain, minimum that lasted for 10 minutes. 3 or 4 night prior reporting the event, the patient was feeling abnormal, went to ER and was hospitalized with severe chest pain. The patient was in a regular room and was transferred to ICU. Next day, Cardiac catheterization was performed to see the patient's heart and found that 3 arteries in the original surgery were failing.  Treatment for the event, severe chest pain included morphine.  Action taken with mRNA-1273 in response to the events was not reported.   The event of arm pain was considered Recovered/Resolved.  The events, abnormal feeling, severe chest pain were considered as unknown. The patient is still hospitalized.; Reporter's Comments: This case concerns a 71-year-old, male patient, who experienced severe chest pain, feeling abnormal. Cardiac catheterization was performed which showed that 3 arteries in the original surgery were failing. Very limited information regarding this event has been provided at this time. The patient's medical history of heart attack (May 2020) and bypass (October 2020) confounds the causality. Further information has been requested.
No additional AE reported; A HCP called and reported an AE where a 15 year old patient received a dose of PROQUAD inadvertently, rather than the scheduled MMR II and VARIVAX. The patient received his first dose of MMR II and VARIVAX in November of 2022. The patient received th; a 15 year old patient received a dose of PROQUAD inadvertently; This spontaneous report was received from a registered nurse, referring to a 15-year-old male patient. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions, or allergies were not reported.  On an unspecified day in November 2022, the patient received his first dose of varicella virus vaccine live (oka/merck) (VARIVAX) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (strengths, anatomical sites of vaccination, routes of administration, lot numbers and expiration dates were not reported).  On 03-MAY-2023, the patient was inadvertently vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) (strength, vaccination scheme, anatomical site of vaccination and route of administration were not reported; lot number W028567, expiration date reported and validated as 06-MAR-2024) as prophylaxis, rather than the scheduled varicella virus vaccine live (oka/merck) (VARIVAX) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (wrong product administered and product administered to patient of inappropriate age). A sterile diluent (MERCK STERILE DILUENT) (strength and route of administration was not reported; lot number W014213, expiration date reported and validated as 20-NOV-2024) was used to administer the inadvertent dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD). No adverse effects were reported.
No side effects reported; Nurse calling to report that PROQUAD was inadvertently administered to a 6 month old. No side effects reported. No additional AE / no PQC.; This spontaneous report was received from a nurse and referred to a 6-month-old female patient. The concomitant therapy, concurrent condition, drug reactions/allergies, and medical history were not provided.  On 01-JUN-2023, the patient inadvertently received the first dose of vaccine with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) 0.5 milliliter for prophylaxis (strength, lot#, expiry date, and route of administration were not provided) (Product administered to patient of inappropriate age). There were no side effects reported and no additional adverse event (No adverse event).
Itchy rash, I  put rubbing alcohol and neosporin on it. It was laRGER THE NEXT DAY.
Left corner of mouth and chin had a red rash. Red rash was also on left top side of his shoulder and created a line traveling down to the bottom on his rib cage. Low grade fever started soon after. Was given 2.5ml of Benadryl within 20mins. Rash disappeared with the hour. Woke up the next day completely dazed, fussy, no appetite, lethargic and with low grade fever. Finally had an appetite around 6pm (24hrs after onset of symptoms). Now on Day 2 of low grade fever, but acting normal.
rash; It started with fatigue; chills; I had extreme body heat; dry skin; burning sensation in my arms and feet; This is a spontaneous report from a contactable consumer (Patient) or other non-HCP.  A 39-year-old male received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was EW0150) via an intramuscular route of administration, administered in Arm Left on 01Apr2021 (at 16:30) (age at the time of vaccination was 39-years-old) as DOSE 1, SINGLE for COVID-19 immunization. Relevant medical history and concurrent conditions included No Gallbladder, have weak digestion because of it from an unspecified date. Concomitant medications received within 2 weeks of vaccination included Vitamin D3 supplement. The patient had no relevant past drug history. The patient had no known allergies. The patient had no prior vaccinations within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. On 01May2021 (at 01:00), the patient experienced It started with fatigue, chills, I had extreme body heat, dry skin, burning sensation in my arms and feet. On 02May2021, the patient experienced rash. The patient received Steroids and antihistamines as treatment medications. The patient underwent lab tests and medical procedures on 10May2021 which included Full blood count which showed result Normal and Metabolic function test which showed result Normal. The clinical outcome of It started with fatigue, chills, I had extreme body heat, dry skin, burning sensation in my arms and feet was Not recovered, while the clinical outcome of rash was unknown.  Follow-Up (20Aug2021): Follow-up attempts are completed. No further information is expected.
difficulty swallowing; listless; poor suck; dialated pupils; sluggish reaction to light;
Information has been received from a physician concerning an approximately 70 year old male with a history of psoriasis who on 26-DEC-2007 was vaccinated with a dose of Zostavax (Oka/Merck). On 27-DEC-2007 the patient went into the office and was diagnosed with abdominal zoster. No further adverse event information. Unspecified medical attention was sought through the physician. There was no product quality complaint. Additional information has been requested.
sore left arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (sore left arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (sore left arm). At the time of the report, PAIN IN EXTREMITY (sore left arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant and Treatment was not specified. Case is crosslinked to MOD21-153943   This case was linked to MOD-2021-356211 (Patient Link).
pt recvd 3 doses of Engerix-B 11MAR91, 12APR91, 24SEP991; pt did not seroconvert;